Results 201 to 210 of about 83,566 (244)
Some of the next articles are maybe not open access.
EFFECTIVE PROTECTION AGAINST INFLUENZA AFTER VACCINATION WITH SUBUNIT VACCINE
Medical Journal of Australia, 1978Immunization with an influenza subunit vaccine given in one dose about 1 month to 2 months before onset of an epidemic of influenza afforded from 80% to 90% protection in a double-blind clinical trial which was supported by isolation of virus and serological studies. In the vaccinated group, 20% failed to develop antibodies to the vaccine.
M L, Hammond +3 more
openaire +2 more sources
Feline calicivirus subunit vaccine - a prototype
Antiviral Research, 1985A vaccine was prepared from a subunit component, antigenically similar to the whole feline calicivirus (FCV) particles. Despite the limited number of animals available for this study we were able to demonstrate that the vaccine protected cats when challenged with a virulent strain of the virus while the non-vaccinates kept as controls developed ...
O O, Komolafe, O, Jarrett
openaire +2 more sources
Design and production of recombinant subunit vaccines
Biotechnology and Applied Biochemistry, 2000The development of subunit vaccines is presently the main strategy being evaluated for prevention of infectious diseases. The use of recombinant‐DNA techniques has facilitated the development of new principles for design and production of subunit vaccines.
M, Hansson, P A, Nygren, S, Ståhl
openaire +2 more sources
Infectious Bursal Disease Subunit Vaccination
Avian Diseases, 2008Infectious bursal disease virus (IBDV) is the causative agent of infectious bursal disease, a nosologic entity with global economic importance in poultry. The viral protein 2 (VP2) is recognized as the virus' major antigenic protein. The goal of this study was to generate yeast (Pichia pastoris)-based protein expression from the VP2 gene of the Edgar ...
Pedro, Villegas +3 more
openaire +2 more sources
KILLED SUBUNIT INFLUENZA VACCINE IN CHILDREN
Pediatrics, 1973Thirty-three children ranging in age from 5 to 9 years were immunized with varying doses of bivalent A2 (Hong Kong variant) B subunit influenza vaccine. The immunization was given intramuscularly. There were no local or systemic reactions. Thirty-one of 33 children (94%) demonstrated four-fold or greater rises in antibody titer to type A antigen ...
C F, Phillips +5 more
openaire +2 more sources
Adjuvants and Subunit Vaccines
20101 Adjuvants 2 Subunit Vaccines 3 Acknowledgments Keywords: adjuvants and subunit vaccines; immunological phenomena-triggered by vaccine adjuvants; antigen-presenting cells (APC)-activation and expansion of antigen-specific T- and B-cell populations.; new vaccine adjuvants; adjuvants licensed for use in humans, MF59; bacterial ...
Giuseppe Del Giudice, Rino Rappuoli
openaire +1 more source
Potency of a Scalable Nanoparticulate Subunit Vaccine
Nano Letters, 2018Nanoparticulate vaccines can potentiate immune responses by site-specific drainage to lymph nodes (LNs). This approach may benefit from a nanoparticle engineering method with fine control over size and codelivery of antigen and adjuvant. Here, we applied the flash nanocomplexation (FNC) method to prepare nanovaccines via polyelectrolyte complexation of
Dongdong Qiao +7 more
openaire +2 more sources
Clinical Trial of a Subunit Influenza Vaccine
Scandinavian Journal of Infectious Diseases, 1981A double-blind field trial was performed comparing a subunit influenza vaccine (A/Victoria/75 and B/Hongkong/73) with placebo. A good protection against influenza was induced by the vaccine. On the basis of serological determinations (enzyme immunoassay, EIA) the incidences of influenza A and B infections were reduced within a period from 3 weeks up to
S, Pyrhönen, J, Suni, M, Romo
openaire +2 more sources
Vaccine, 2012
Genetic immunization holds promise as a vaccination method, but has so far proven ineffective in large primate and human trials. Herein, we examined the relative merits of genetic immunization and peptide immunization using bacteriophage λ. Bacteriophage λ has proven effective in immune challenge models using both immunization methods, but there has ...
Brad S, Thomas +8 more
openaire +2 more sources
Genetic immunization holds promise as a vaccination method, but has so far proven ineffective in large primate and human trials. Herein, we examined the relative merits of genetic immunization and peptide immunization using bacteriophage λ. Bacteriophage λ has proven effective in immune challenge models using both immunization methods, but there has ...
Brad S, Thomas +8 more
openaire +2 more sources
The case for a subunit vaccine against malaria
Trends in Parasitology, 2011New technologies and some disillusionment with subunit vaccines has led to increased interest in the development of whole parasite vaccines for malaria. Instead, the current priority should be to build on the partial success of the recombinant protein sporozoite vaccine, RTS,S.
openaire +2 more sources

